Sarah Clements

IAG Airlines

When GSK decided to undertake one of the biggest UK corporate demergers of the 21st century, Sarah Clements was tasked with the job of overseeing the legal aspect as head of transformation and separation.

An event that was years in the making, Clements’ deep operational experience and knowledge from  previous roles at Alexion Pharmaceuticals and Novartis enabled her to play a fundamental role in getting the merger over the line. Working closely with a large number of departments, stakeholders, and responsible for a number of ground-breaking moments such as getting the board approvals for the demerger, she played a fundamental part in getting the separation over the line.

The £28.5bn listing of the end-product, Haleon, demonstrates the complexity and magnitude of Clements’ undertaking as part of the wider GSK team involved. Since then she’s moved on to her next challenge, joining FTSE 100 giant International Airlines Group as its new general counsel.